CytRx Corporation (Nasdaq: CYTR) announced the appointment of Felix Kratz, Ph.D. as Vice President of Drug Discovery and André Warnecke ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE